Get started

MED

Growing Revenue, TWST Set to Launch?Digital Health & Medical AI is on the rise ...and so is TWST's Revenue. It is tipped that artificial intelligence will play a key role in the development of industry wide efficiencies, with many advancements occurring over the last 12 months within the Medical Technologies space. One key player could be TWIST Bioscience Corporation NASDAQ:TWST , who have developed a synthetic DNA manufacturing process. Momentum Guide - Rating has now been upgraded to 'Bullish'. Here's our price guide: Bullish Continuation Potential above $48.71 Bearish Continuation Risk below $39.93 We're inspired to bring you the latest developments across worldwide markets, helping you look in the right place, at the right time - We will continue to monitor the Digital Health space in the event there are any rapid changes. Thank you for reading! Stay tuned for further updates, and we look forward to being of service along your trading & investing journey... Please note all information contained within this post is strictly for informational purposes only and is not intended to be investment advice. Please DYOR & Consult your licensed financial advisors before acting on any information contained within this post. Love & Wisdom,
NASDAQ:TWSTLong
by Bullfinder-official
Moderna - Correction Almost Done!Hello TradingView Family / Fellow Traders. This is Richard, also known as theSignalyst. 📈 MRNA has been overall bullish , trading above the trendline marked in blue. Currently, MRNA is undergoing a correction phase in the shape of a falling channel. Moreover, it is retesting massive support zone in green. 🏹 Thus, the highlighted blue circle is a strong area to look for trend-following buy setups as it is the intersection of the green support and lower blue/red trendlines acting as non-horizontal support. 📚 As per my trading style: As #MRNA approaches the blue circle zone, I will be looking for bullish reversal setups (like a double bottom pattern, trendline break , and so on...) 📚 Always follow your trading plan regarding entry, risk management, and trade management. Good luck! All Strategies Are Good; If Managed Properly! ~Rich
NASDAQ:MRNALong
by TheSignalyst
$MED Oversold and Due For A Bounce$MED is now extremely oversold with an RSI just above 20. After missing earnings last Friday, what's notable is that traders did buy the dip and we got a green candle on the day. We believe this is a sign that $MED is now too cheap to ignore. $MED is now trading at just 12x earnings and a PEG of 0.62. Medifast (NYSE:MED) closed down 27% on the heels of its Q3 report. Highlights: Revenue: $190.1M (+36.5%). Net income: $15.9M (+15.4%); EPS: $1.32 (+15.8%). Q4 guidance: Revenue: $157M - 167M; EPS: $1.03 - 1.13. 2019 guidance: Revenue: $700M - 710M from $730M - 750M; EPS: $5.80 - 5.90 from $6.75 - 6.95. Guidance revised due to "short-term challenges." Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, franchise weight loss clinics, and direct consumer marketing. The company was founded in 1980 and is headquartered in Baltimore, Maryland. As always, trade with caution and use protective stops. Good luck to all!
NYSE:MEDLong
by InsiderFinancial